Drug delivery assembly with sensor sampling feature

The drug delivery assembly addresses the challenge of inaccurate dose logging by using sensor systems that adapt sampling frequency based on rotational speed, ensuring precise and efficient dose capture.

JP2024161371AInactive Publication Date: 2024-11-19NOVO NORDISK AS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024114111
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-11-06
Filing Date
2024-07-17
Publication Date
2024-11-19
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing drug delivery devices lack efficient and reliable methods for capturing and logging dose data, leading to inaccurate patient records that can misinform healthcare decisions.

Method used

A drug delivery assembly with integrated or add-on sensor systems that measure rotational movement of an indicator component using magnetic or optical sensors, adjusting sampling frequency based on rotational speed to optimize power consumption and accuracy.

Benefits of technology

Provides reliable and power-efficient dose capture, reducing errors in patient records and enhancing healthcare decision-making.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024161371000001_ABST
    Figure 2024161371000001_ABST
Patent Text Reader

Abstract

To provide a drug delivery assembly comprising a sensor system in combination with an indicator arranged to rotate, where an amount of rotation is indicative of a size of an expelled dose amount.SOLUTION: The sensor system includes a sensor assembly adapted to measure a rotational position and / or rotational movement of the indicator, the sensor assembly including a sensor element adapted to be operated at a non-constant sampling frequency. A processor is configured to determine, on the basis of measured values from the sensor element, rotational position(s) and / or an amount of rotational movement of the indicator, as well as a rotational speed of the indicator. To optimize energy consumption, the processor is configured to dynamically control the sampling frequency in response to the determined rotational speed.SELECTED DRAWING: Figure 5
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] The present invention relates generally to medical devices associated with data generation, collection, and storage. In particular embodiments, the present invention relates to devices, systems, and methods for capturing drug delivery dose data in a reliable and efficient manner. [Background technology]

[0002] In this disclosure, reference is made primarily to drug delivery devices including a threaded piston rod driven by a rotary drive member, and such devices are used, for example, in the treatment of diabetes by insulin delivery, although this is merely an exemplary use of the invention.

[0003] Drug injection devices have greatly improved the lives of patients who need to self-administer drugs and biological agents. Drug injection devices can take many forms, including simple disposable devices that are little more than an ampoule with an injection means, or they can be durable devices adapted for use with pre-filled cartridges. Regardless of their form and type, they have proven to be a great help in assisting patients to self-administer injectable drugs and biological agents. They also greatly assist caregivers in administering injectable medications to those who are unable to perform self-injections.

[0004] Administering the required amount of insulin at the appropriate time and in the appropriate size is essential for managing diabetes; i.e., adhering to a prescribed insulin regimen is important. Diabetic patients are encouraged to keep a log of the size and time of each injection to enable healthcare professionals to determine the effectiveness of the prescribed dosing pattern. However, such logs are typically recorded in handwritten notebooks, and the logged information may not be easily uploaded to a computer for data processing. Furthermore, because only events noted by the patient are logged, notebook systems require the patient to remember to log each injection if the logged information is to have any value in treating the patient's diabetes. Missing or incorrect entries in the log can result in an incorrect picture of the injection history, which in turn can result in an incorrect basis for healthcare professionals' decision-making regarding future drug therapy. Therefore, it may be desirable to automate the logging of injection information from medication delivery systems.

[0005] While some injection devices integrate this monitoring / acquisition mechanism into the device itself, as disclosed in, for example, US2009 / 0318865 and WO2010 / 052275, most devices today do not. The most widely used devices are simply mechanical devices that are either durable or pre-filled. The latter devices are inexpensive because they are discarded after being emptied, making it cost-prohibitive to build electronic data acquisition capabilities into the device itself. To address this problem, many solutions have been proposed that would help users generate, collect, and distribute data representing the use of a given medical device.

[0006] For example, WO 2014 / 037331 describes in a first embodiment an electronic auxiliary device (also referred to as an "add-on module" or "add-on device") adapted to be removably attached to a pen-type medication delivery device. The device includes a camera and is configured to perform optical character recognition (OCR) of an image captured from a rotating scale drum visible through a dosing window of the medication delivery device to determine the dose of medication dialed into the medication delivery device. WO 2014 / 037331 also describes a second embodiment of an electronic auxiliary device adapted to be removably attached to a pen-type medication delivery device including a drive screw extending proximally from the device corresponding to the set dose. The auxiliary device includes sensor means for determining the axial extension of the drive screw and sensor means for detecting operation of a proximal delivery button. WO 2014 / 020008 discloses an electronic auxiliary device adapted to be removably attached to a pen-type medication delivery device. The device includes a camera and is configured to determine a scale drum value based on OCR. In order to properly determine the size of the expelled dose, the auxiliary device further comprises additional electromechanical sensor means for determining whether the dose size is being set, modified or delivered. Further external devices for pen-based devices are shown in WO 2014 / 161952 and EP 3 103 492. Summary of the Invention [Problem to be solved by the invention]

[0007] In view of the above, it is an object of the present invention to provide an apparatus and method that allows safe, simple and efficient data capture for a drug delivery assembly that includes sensor means for determining the size of the dispensed drug quantity. The sensor means may be integrated into the drug delivery device or may be provided as a user-installable add-on device. [Means for solving the problem]

[0008] In the present disclosure, embodiments and aspects are described that address one or more of the above objects or that address objects that are apparent from the following disclosure as well as the description of exemplary embodiments.

[0009] Considering external dosing from a conventional piston-based medication delivery device, either spring-driven or manually driven by a user, medication is expected to be ejected at a steady state, indicating that the ejection mechanism based on rotational motion input (i.e., rotational motion of a driver component is translated into axial motion of a piston rod that moves the cartridge piston distally to eject a set dose) also rotates at a corresponding steady state. For a given sensor system designed to determine the amount of rotation of a given indicator member (i.e., the rotating ejection mechanism component that corresponds to the size of the ejected dose), this allows for the specification of a required sampling frequency. The sampling rate is specified to achieve the lowest possible power consumption, and the lowest possible, yet still sufficient, power consumption.

[0010] The present invention is based on the recognition that although external dosing from a drug delivery device appears to occur in a steady linear state, the corresponding axial movement of the piston driver (i.e., typically the piston rod), and therefore the rotational movement of certain components in the ejection mechanism, is not linear.

[0011] Essentially, all commercially known drug cartridges for drug delivery systems are provided with pistons made of elastic materials, such as rubber, introducing an elastic component that has been found to affect external dosing. More specifically, it has been found that axial compression of the rubber piston initially occurs during an external dosing event, and this initial compression occurs at a faster axial speed than the continuous expulsion of drug through a hollow hypodermic needle. Correspondingly, a higher sampling rate would be required to enable the sensor system to reliably detect the rotational momentum of a given indicator component even during the initial phase of an external dosing event.

[0012] Having addressed this issue, a further related problem is also addressed: in the case of the piston driver, i.e. the element that actually applies the axial driving force of the piston, which is generally the piston rod, may initially, and for some reason, be positioned at a distance from the proximal surface of the piston, thereby establishing a so-called air gap that corresponds to the elastic compression of the piston, which in turn results in the initial fast axial and rotational movements of the components of the drug ejection mechanism.

[0013] To address this issue, the present invention in a first aspect provides a drug delivery assembly including a housing, a drug reservoir or means for receiving a drug reservoir, a drug ejection means, and a sensor system. The drug ejection means includes a dose setting means that allows a user to set a dose of drug to be ejected, a release means that is operable to allow the drug ejection means to eject the set dose, and an indicator that is adapted to rotate relative to the housing during ejection of the drug dose, the amount of rotation indicating the size of the ejected dose. The sensor system includes a sensor assembly that is adapted to measure a characteristic of the indicator indicative of the rotational position and / or rotational movement of the indicator, the sensor assembly including at least one sensor element adapted to operate at a first sampling frequency and at least one sensor element adapted to operate at a second, lower sampling frequency, and a processor configured to determine (i) the rotational position(s) and / or amount of rotational movement of the indicator and (ii) the rotational speed of the indicator based on measurements from the at least one sensor element. The sensor system is operable between an inactive state and an active state. When the sensor system is activated, the at least one sensor element operates at a first sampling frequency, and when a decrease in rotational speed is detected, the at least one sensor element operates at a second sampling frequency.

[0014] This arrangement addresses the special situation associated with the initial external dispensing of a fluid medication from a medication delivery device, as well as the general need for reliable and power-efficient dose sizing.

[0015] The concept of operating sensors at different sampling frequencies in response to the detection of the drug delivery device leaving the initial compression / air gap phase and entering the slower, primary external dosing state can be achieved in several ways. For example, a dedicated sensor element with low power consumption can operate at a high sampling rate in the initial phase, while a sensor element with high power consumption can operate at a lower sampling rate thereafter. As mentioned above, the first sensor used should be able to properly determine the rotational position of the indicator element. Alternatively, a sensor element suitable for both high and low sampling rates can be utilized, similar to the implementation of a mixed setup using many different sensor elements.

[0016] Correspondingly, in an exemplary embodiment, the sensor assembly includes at least one sensor element adapted to operate at a non-punctual sampling frequency. When the sensor system is activated, the at least one sensor element adapted to operate at the non-punctual sampling frequency operates at a first sampling frequency, and when a decrease in rotational speed is detected, the sampling frequency is reduced to a second sampling frequency for the at least one sensor element adapted to operate at the non-punctual sampling frequency, initially operated at the first sampling frequency. Or, in shorter terms, the same sensor element operates at two different sampling frequencies.

[0017] The sampling frequency of the at least one sensor element may be controlled according to one or more predetermined thresholds for the rotational speed.

[0018] The sensor assembly may include a plurality of sensor elements, with a first number of sensors operating at a first sampling frequency for each sample and a second, greater number of sensors operating at a lower sampling frequency for each sample when a decrease in rotational speed is detected.

[0019] In certain embodiments, the indicator includes a magnetic component and at least one sensor element is a magnetic sensor adapted to measure one or more components of a magnetic field, where the at least one magnetic sensor may be operated at a non-timed sampling frequency pursuant to detection of a decrease in rotational speed. Alternatively, an optical sensor may be used in combination with, for example, a visual marker located on the indicator.

[0020] The term "sensor element" may refer to a single sensor component, e.g., an optical sensor, but may also refer to a functional part of a sensor component. For example, a "compass-type" magnetic sensor is adapted to measure magnetic field values ​​in three directions, and for a given direction, the corresponding sensor structure can often operate independently and therefore represents an individual sensor element.

[0021] In certain embodiments, the above-described drug delivery assembly may include a generally cylindrical drug reservoir having an axially movable piston formed from a resilient material that is loaded into a cartridge holder or provided as part of a disposable pre-filled device.

[0022] In a particular aspect of the present invention, there is provided a medication delivery assembly as described above, comprising a medication delivery device and an add-on device adapted to be removably mounted on the medication delivery device, wherein the medication delivery device comprises a housing, a medication reservoir or means for receiving a medication reservoir, and a medication ejection means, while the add-on device comprises a sensor system.

[0023] In an exemplary embodiment, the medicament ejection means includes a rotatable dose setting member that allows a user to set a dose of the medicament to be ejected, a release member actuatable between a proximal position and a distal position, the proximal position allowing the dose to be set and the distal position allowing the medicament ejection means to eject the set dose, and a drive spring that is arranged to be deformed during dose setting and is released by the release member, thereby driving the ejection of an amount of medicament from the medicament reservoir. The add-on device further includes an add-on housing adapted to be removably attached to the medicament delivery device housing, an add-on dose setting member adapted to directly or indirectly engage with the dose setting member, and an actuatable add-on release member that is axially movable relative to the add-on dose setting member between (i) a proximal dose setting position at which, when the add-on device is attached to the medicament delivery device, the add-on dose setting member can be operated to rotate the dose setting member to set the dose, and (ii) a distal dose release position at which, when the add-on device is attached to the medicament delivery device, the release member moves to its distal position to release the set dose.

[0024] In a further aspect, there is provided an add-on drug delivery assembly adapted to be removably mounted on a drug delivery device comprising a housing, a drug reservoir or means for receiving the drug reservoir, and drug ejection means including dose setting means for enabling a user to set a dose of drug to be ejected, release means operable to enable the drug ejection means to eject the set dose, and an indicator adapted to rotate relative to the housing during ejection of the dose of drug, the amount of rotation being indicative of the size of the ejected dose. The add-on device includes an add-on housing adapted to be removably attached to the medication delivery device housing; a sensor assembly adapted to measure a characteristic of an indicator indicative of a rotational position and / or rotational movement of the indicator when the add-on device is attached to the medication delivery device, the sensor assembly including at least one sensor element adapted to operate at a first sampling frequency and at least one sensor element adapted to operate at a second, lower sampling frequency; and a processor configured to determine (i) the rotational position(s) and / or amount of rotational movement of the indicator and (ii) the rotational speed of the indicator based on measurements from the at least one sensor element. The sensor system is operable between a non-operational state and an operation state. When the sensor system is activated, the at least one sensor element operates at the first sampling frequency, and when a decrease in the rotational speed is detected, the at least one sensor element operates at the second, lower sampling frequency.

[0025] The at least one sensor element may operate initially at a first sampling frequency and thereafter at a second, lower sampling frequency when a decrease in rotational speed is detected.

[0026] In an exemplary embodiment, the indicator includes a magnetic component and the at least one sensor element is in the form of a magnetic sensor adapted to measure one or more components of a magnetic field generated by the indicator magnetic component.

[0027] The sampling frequency of the at least one sensor element may be controlled according to one or more predetermined thresholds for the rotational speed.

[0028] The sensor assembly may include multiple sensor elements, whereby a first number of sensors operate for each sample at a first sampling frequency and a second, greater number of sensors (e.g., the same sensor(s) and / or additional sensors) operate at a lower sampling frequency for each sample when a decrease in rotational speed is detected.

[0029] In yet a further aspect of the present invention, a medication delivery assembly for capturing dose-related data from a medication delivery assembly is provided, the method comprising the steps of (i) providing a medication delivery assembly including a housing, a medication reservoir or means for receiving a medication reservoir, medication ejection means, and a sensor system, the medication ejection means including dose setting means for enabling a user to set a dose of medication to be ejected, release means operable to enable the medication ejection means to eject the set dose, and an indicator adapted to rotate relative to the housing during ejection of the medication dose, the amount of rotation being indicative of the size of the ejected dose. The sensor system includes a sensor assembly adapted to measure a characteristic of an indicator indicative of a rotational position and / or rotational movement of the indicator, the sensor assembly including at least one sensor element adapted to operate at a first sampling frequency and at least one sensor element adapted to operate at a second, lower sampling frequency, and a processor configured to determine (i) the rotational position(s) and / or amount of rotational movement of the indicator and (ii) the rotational speed of the indicator based on measurements from the at least one sensor element. The method further includes (ii) actuating the sensor system from a non-operational state to an operation state, (iii) operating the at least one sensor element at the first sampling frequency, (iv) detecting the rotational speed of the indicator, and (v) operating the at least one sensor element at the second, lower sampling frequency when a decrease in the rotational speed is detected.

[0030] The mode of operation of the provided drug delivery assembly as well as the sensor element may be varied as described above in the disclosure of the corresponding drug delivery assembly.

[0031] In an even more general aspect of the present invention, a universal sensor system adapted for use in combination with an indicator is provided, the indicator being disposed for rotation relative to a reference component and corresponding to a reference axis. The sensor system includes a sensor assembly adapted to measure a characteristic of the indicator indicative of the rotational position and / or rotational movement of the indicator, the sensor assembly including at least one sensor element adapted to operate at a non-timed sampling frequency. The sensor system further includes a processor configured to determine the rotational position(s) and / or amount of rotational movement of the indicator and a rotational speed of the indicator based on measurements from the at least one sensor element. In such a system, the processor is configured to dynamically control the sampling frequency in response to the determined rotational speed.

[0032] This arrangement allows for reliable and power-efficient determination of the indicator's rotational movement and position to be achieved.

[0033] The sensor system may be operable between a non-operating state and an operating state, where the sensor system operates at an initial sampling frequency when activated and the sampling frequency is reduced when a decrease in rotational speed is detected. The sampling frequency may be controlled according to one or more predetermined thresholds for rotational speed. Alternatively, or additionally, the sampling frequency may vary continuously with rotational speed for a predetermined range of rotational speeds.

[0034] In an exemplary embodiment, the indicator includes a magnetic component and the at least one sensor element is a magnetic sensor adapted to measure one or more components of a magnetic field.

[0035] In certain embodiments, a medication delivery system is provided, including a medication delivery device and an add-on device adapted to be removably mounted on the medication delivery device. The medication delivery device includes a housing forming a reference component, a medication reservoir or means for receiving the medication reservoir, a medication ejection means including a rotatable dose setting member that allows a user to set a dose of medication to be ejected, a release member actuable between a proximal position and a distal position, the proximal position allowing the dose to be set and the distal position allowing the medication ejection means to eject the set dose, a drive spring arranged to be deformed during dose setting and released by the release member, thereby driving the ejection of a quantity of medication from the medication reservoir, and the indicator as described above. The indicator is adapted to move during dose setting and / or ejection, the amount of movement being indicative of the set and / or ejected dose. The add-on device includes a sensor system as described above, wherein the detected rotational position(s) and / or amount of rotational movement of the indicator correspond to the set and / or ejected dose.

[0036] In a further particular embodiment, there is provided a drug delivery device including a sensor system as described above. The drug delivery further comprises a housing forming a reference component, a drug reservoir or means for receiving the drug reservoir, drug ejection means comprising a rotatable dose setting member that allows a user to set a dose of drug to be ejected, a release member actuatable between a proximal position and a distal position, the proximal position allowing the dose to be set and the distal position allowing the drug ejection means to eject the set dose, a drive spring arranged to be deformed during dose setting and released by the release member, thereby driving the ejection of an amount of drug from the drug reservoir, and an indicator. The indicator is adapted to move during dose setting and / or ejection, the amount of movement of which is indicative of the size of the dose to be set and / or ejected, wherein the determined rotational position(s) and / or amount of rotational movement of the indicator element correspond to the dose to be set and / or ejected.

[0037] When the term "member" is used above, this term also encompasses an assembly that includes multiple components.

[0038] As used herein, the term "insulin" is meant to encompass any drug-containing, flowable pharmaceutical product that can be passed in a controlled manner through a delivery means, such as a cannula or hollow needle, as a liquid, solution, gel, or fine suspension, and that has a glycemic control effect. For example, human insulin and its analogs, and non-insulins such as GLP-1 and its analogs. In describing the exemplary embodiments, reference is made to the use of insulin, but the described modules can also be used to generate logs for other types of drugs (e.g., growth hormone).

[0039] Hereinafter, the following embodiments of the present invention will be described with reference to the drawings. [Brief explanation of the drawings]

[0040] [Figure 1A] FIG. 1A shows a pen-based device. [Figure 1B] FIG. 1B shows the pen device of FIG. 1A with the pen cap removed. [Figure 2] FIG. 2 shows an exploded view of the components of the pen device of FIG. 1A. [Figure 3A-3B] 3A and 3B show cross-sectional views of the ejection mechanism in two states. [Figure 4A-4B] 4A and 4B show schematic diagrams of the add-on device and the drug delivery device. [Figure 5] FIG. 5 shows in cross section an add-on device mounted on the housing of a medication delivery device. [Figure 6] FIG. 6 shows a second embodiment of an add-on device in combination with a drug delivery device. [Figures 7A-7B] 7A and 7B show cross-sectional views of the add-on device of FIG. [Figure 7C]FIG. 7C shows details of the electronic sensor circuitry incorporated into the add-on device of FIG. 7A. [Figures 8A-8D] 8A-8D show an assembly including the add-on device of FIG. 6 installed on a medication delivery device in cross-section and in different operational states. [Figure 9] FIG. 9 shows an exploded view of the components of a third embodiment of an add-on device. [Figures 10A-10B] 10A and 10B show the components of the add-on device of FIG. 9 installed on a pen-based device in different states. [Figures 11A-11B] 11A and 11B show cross-sectional views of the device shown in FIGS. 10A and 10B. [Figures 12A-12B] 12A and 12B show the third embodiment in an assembled state in a partial cutaway view. [Figures 13A-13F] 13A-13F show cross-sectional views of the third embodiment in a series of operating states. [Figure 14] FIG. 14 shows individual dipole magnets arranged equidistantly within a tracer element in the form of a ring. [Figure 15A] FIG. 15A shows a tracer component made from a magnetizable material interdigitated and disposed between individual magnets. [Figure 15B] FIG. 15B shows a tracer component made from a magnetizable material disposed within a multipole electromagnetic field. [Figure 16] FIG. 16 shows a different embodiment of a sensor system that includes a magnetometer disposed relative to a tracer component. [Figure 17A] FIG. 17A shows the angle measurements for a bipolar tracer magnet in combination with the first sensor setup. [Figure 17B] FIG. 17B shows the angular measurements of the quadrupole tracer magnet in combination with the second sensor setup. [Figure 18] FIG. 18 shows the signal from the quadrupole magnet over one complete rotation of the magnet. [Figure 19] FIG. 19 shows a map of the frequency content of the signal from FIG. [Figure 20] FIG. 20 shows the assembly of the quadrupole magnet and seven magnetometers. [Figure 21] FIG. 21 shows a further embodiment of an add-on device mounted on a medication delivery device. [Figure 22] FIG. 22 shows yet a further embodiment of an add-on device mounted on a medication delivery device. [Figures 23A-23B] 23A and 23B show first and second examples of static sampling strategies. [Figure 24] FIG. 24 shows an example of a dynamic sampling strategy.

[0041] In the drawings, like structures are primarily identified by like reference numbers. DETAILED DESCRIPTION OF THE INVENTION

[0042] When the following terms, such as "top" and "bottom," "right" and "left," "horizontal" and "vertical," or similar relative expressions, are used, they refer solely to the accompanying figures and do not necessarily represent actual use. The depicted figures are schematic representations, and therefore the configuration of different structures as well as their relative dimensions are intended to serve illustrative purposes only. When the term "member" or "element" is used for a given component, this generally represents that this component is a single component in the described embodiment; alternatively, the same member or element may include several subcomponents, such that two or more of the described components may be provided as a single component, e.g., may be manufactured as a single injection-molded part. The term "assembly" does not imply that the described components need to be assembled to provide a single or functional assembly during a given assembly procedure, but is merely used to describe components that are grouped together as more closely related functionally.

[0043] Before returning to embodiments of the invention itself, one example of pre-filled medication delivery will be described, and such a device will provide the basis for exemplary embodiments of the invention. The pen-type medication delivery device 100 shown in Figures 1-3 may represent a "generic" medication delivery device; the device actually shown is a FlexTouch® pre-filled medication delivery pen manufactured and sold by Novo Nordisk A / S, Bagsvaerd, Denmark.

[0044] The pen device 100 comprises a main portion having a cap member 107 and a proximal body or drive assembly portion having a housing 101 in which a medication ejection mechanism is disposed or integrated, and a distal cartridge holder portion in which a medication-filled transparent cartridge 113 having a distal needle-pierceable septum is disposed and held in place by a non-removable cartridge holder affixed to the proximal portion, the cartridge holder having an opening that allows a portion of the cartridge to be inspected, as well as a distal connection means 115 that allows a needle assembly to be removably installed. The cartridge is provided with a piston driven by a piston rod that forms part of the ejection mechanism and may contain, for example, insulin, GLP-1, or growth hormone preparations. A proximal-most rotatable dose setting member 180 having a number of axially oriented grooves 182 functions to manually set the desired dose of medication shown in the display window 102 and then eject it when a button 190 is actuated. As will become apparent from the description below, the axially oriented grooves 182 shown may be referred to as "drive grooves." The dose setting member 180 has a generally cylindrical outer surface 181 (i.e., the dose setting member may be slightly tapered), and in the illustrated embodiment, the outer surface is textured by including a plurality of axially oriented microgrooves to improve finger grip during dose setting. The window is in the form of an opening in the housing surrounded by the chamfered edge portion 109 and the dose pointer 109P, allowing observation of a portion of the spirally rotatable indicator member 170 (scale drum). Depending on the type of ejection mechanism embodied in the medication delivery device, the ejection mechanism may include a spring that is deformed during dose setting and then released when a release button is actuated to drive the piston rod, as shown in the embodiment. Alternatively, the ejection mechanism may be entirely manual, in which case the dose member and actuation button are moved proximally during dose setting corresponding to the set dose size, and then moved distally by the user to eject the set dose, as in, for example, the FlexPen® manufactured and sold by Novo Nordisk A / S.

[0045] Although Figure 1 shows a drug delivery device of the pre-filled type, i.e., it is supplied with a cartridge pre-installed and is discarded when the cartridge is emptied, in alternative embodiments the drug delivery device may be designed to be replaceable with a filled cartridge, for example in the form of a "rear-loading" drug delivery device in which the cartridge holder is adapted to be removed from the main part of the device, or alternatively in the form of a "front-filling" device in which the cartridge is inserted through a distal opening into a cartridge holder that is non-removably attached to the main part of the device.

[0046] Since the present invention relates to electronic circuits adapted to interact with drug delivery devices, exemplary embodiments of such devices will be described for a better understanding of the invention.

[0047] Figure 2 shows an exploded view of the pen-type medication delivery device 100 shown in Figure 1. More specifically, the pen comprises a tubular housing 101 having a window opening 102, onto which a cartridge holder 110 is fixedly mounted, with a pre-filled cartridge 113 disposed within the cartridge holder. The cartridge holder is provided with distal connection means 115 that allows a needle assembly 116 to be removably mounted thereon, and proximal connection means in the form of two opposing protrusions 111 that allow a cap 107 to be removably mounted over the cartridge holder and attached needle assembly, and protrusion 112 that prevents the pen from rolling, for example, on a tabletop. A nut element 125 is fixedly mounted to the distal end of the housing, the nut element including a central threaded bore 126, and a spring base member 108 having a central opening is fixedly mounted to the proximal end of the housing. The drive system includes a threaded piston rod 120 having two opposing longitudinal grooves and received within a threaded bore in the nut element; a piston rod drive element 130 in the form of a ring rotatably disposed within the housing; and a clutch element 140 in the form of a ring that rotationally engages the drive element (see below), allowing axial movement of the clutch element. The clutch element is provided with external spline elements 141 adapted to engage corresponding splines 104 (see FIG. 3B) on the inner surface of the housing, allowing the clutch element to move between a rotationally locked proximal position in which the splines are engaged and a rotationally free distal position in which the splines are disengaged. As just described, in both positions, the clutch element is rotationally locked relative to the drive element. The drive element includes a central bore with two opposing protrusions 131 that engage with the grooves in the piston rod, such that rotation of the drive element results in rotation of the piston rod, and thereby distal axial movement, due to the threaded engagement between the piston rod and the nut element. The drive element further includes a pair of opposed, circumferentially extending flexible ratchet arms 135 adapted to engage corresponding ratchet teeth 105 disposed on the housing inner surface.The drive element and clutch element include cooperating coupling structure that rotationally locks them together but allows the clutch element to move axially to its distal position where it can rotate, thereby transmitting rotational movement from the dial system (see below) to the drive system. The interaction between the clutch element, drive element, and housing is shown and described in more detail with reference to Figures 3A and 3B.

[0048] Threaded onto the piston rod is an end-of-volume (EOC) member 128, and rotatably mounted on its distal end is a washer 127. The EOC member includes a pair of opposed radial protrusions 129 for engaging the reset tube (see below).

[0049] The dial system includes a ratchet tube 150, a reset tube 160, a scale drum 170 having a pattern forming a spirally arranged dose-indicating row on its exterior, a dial member 180 operated by a user to set the dose of medication to be dispensed, a release button 190, and a torque spring 155 (see FIG. 3). The dial member is provided with a circumferential internal tooth structure 181 that engages with a number of corresponding external teeth 161 disposed on the reset tube, providing a dial linkage that is engaged when the reset tube is in a proximal position during dose setting and disengaged when the reset tube moves distally during dose ejection. The reset tube is axially locked and mounted inside the ratchet tube but can rotate several degrees (see below). The reset tube includes two opposing longitudinal grooves 169 on its inner surface that are adapted to engage the radial protrusions 129 of the EOC member, allowing the EOC to rotate with the reset tube but move axially. A clutch element is axially locked and mounted on the outer distal end portion of ratchet tube 150, allowing the ratchet tube to move axially into and out of rotational engagement with the housing via the clutch element. A dial member 180 is axially locked and mounted but rotationally free on the proximal end of the housing, and a dial ring is rotationally locked to the reset tube (see below) under normal operation, such that rotation of the dial ring results in corresponding rotation of reset tube 160 and thereby the ratchet tube. A release button 190 is axially locked to the reset tube but is free to rotate. A return spring 195 provides a proximally directed force on the button and the reset tube attached thereto.A scale drum 170 is disposed in the circumferential space between the ratchet tube and the housing, the drum being rotationally locked to the ratchet tube via cooperating longitudinal splines 151, 171 and in rotational threaded engagement with the inner surface of the housing via cooperating thread formations 103, 173 so that the series of numbers passes through window openings 102 in the housing as the drum is rotated relative to the housing by the ratchet tube. A torque spring is disposed in the circumferential space between the ratchet tube and the reset tube and is fixed at its proximal end to spring base member 108 and at its distal end to the ratchet tube so that the spring is deformed when the ratchet tube is rotated relative to the housing by rotation of the dial member. A ratchet mechanism is provided having a flexible ratchet arm 152 between the ratchet tube and the clutch element, the clutch element being provided with a circumferential internal tooth structure 142, each tooth providing a ratchet stop so that the ratchet tube is held in the position to which it has been rotated by the user via the reset tube when the dose is set. To allow for reduction of the set dose, a ratchet release mechanism 162 is provided on the reset tube and acts on the ratchet tube, which allows the set dose to be reduced by one or more ratchet increments by rotating the dial member in the opposite direction, the release mechanism being activated when the reset tube is rotated the aforementioned number of degrees relative to the ratchet tube.

[0050] Having described the different components of the ejection mechanism and their functional relationships, the operation of the mechanism will now be described, primarily with reference to Figures 3A and 3B.

[0051] The pen mechanism can be viewed as two interacting systems: a dose system and a dial system, as described above. During dose setting, the dial mechanism rotates, loading the torsion spring. The dose mechanism is locked to the housing and cannot move. When the push button is pressed, the dose mechanism is released from the housing, and due to its engagement with the dial system, the torsion spring now rotates the dial system back to its starting point, rotating the dose system with it.

[0052] The central part of the dose mechanism is the piston rod 120, which is responsible for the actual displacement of the piston. During dose delivery, the piston rod is rotated by the drive element 130, and thread interaction with a nut element 125 fixed to the housing causes the piston rod to move forward in the distal direction. A piston washer 127 is positioned between the rubber piston and the piston rod, which acts as an axial bearing for the rotating piston rod and equalizes pressure on the rubber piston. The piston rod has a non-circular cross-section through which the piston rod drive element engages the piston rod, so that the drive element is rotationally locked relative to the piston rod but moves freely along the piston rod axis. As a result, rotation of the drive element causes linear forward movement of the piston. The drive element is provided with a small ratchet arm 134 that prevents the drive element from rotating clockwise (as viewed from the end of the push button). Therefore, due to engagement with the drive element, the piston rod can only move forward. During dose delivery, the drive element rotates counterclockwise and the ratchet arm 135 also provides a small click sound to the user by engaging the ratchet teeth 105, for example one click per unit of insulin expelled.

[0053] Turning to the dial system, doses are set and reset by rotating the dial member 180. When the dial is turned, the reset tube 160, EOC member 128, ratchet tube 150, and scale drum 170 all rotate with it due to the engaged dial linkage. The ratchet tube is connected to the distal end of the torque spring 155, thereby loading the spring. During dose setting, the ratchet arm 152 performs a dial click for each dialed increment due to interaction with the internal tooth structure 142 of the clutch element. In the illustrated embodiment, the clutch element is provided with 24 ratchet stops, providing 24 clicks (increments) for a full 360-degree rotation relative to the housing. The spring is preloaded during assembly, allowing the mechanism to deliver both small and large doses within acceptable speed intervals. The scale drum is rotatably engaged with the ratchet tube but is also axially movable, and the scale drum is threadedly engaged with the housing so that when the dial system is rotated, the scale drum moves in a spiral pattern and a number corresponding to the set dose is displayed in the housing window 102.

[0054] A ratchet 152, 142 between the ratchet tube and the clutch element 140 prevents the spring from back-rotating the parts. During reset, the reset tube moves the ratchet arm 152, thereby releasing the ratchet with each click, which in the described embodiment corresponds to one unit of insulin IU. More specifically, when the dial element is rotated clockwise, the reset tube simply rotates the ratchet tube, allowing the ratchet arm to freely interact with the clutch element tooth structure 142. When the dial element is rotated counterclockwise, the reset tube directly interacts with the ratchet click arm, pushing the click arm away from the teeth in the clutch and toward the center of the pen, thus allowing the click arm on the ratchet to move back "one click" due to the torque generated by the loaded spring.

[0055] To deliver the set dose, the push button 190 is pushed distally by the user, as shown in FIG. 3B. The dial linkages 161, 181 are disengaged, and the reset tube 160 is disengaged from the dial member, after which the clutch element 140 disengages from the housing spline 104. The dial mechanism, along with the drive element 130, now returns to "zero," which results in a dose of medication being expelled. It is possible to stop and start the dose at any time during medication delivery by releasing or depressing the push button. Doses less than 5 IU typically cannot be paused, as compressing the rubber piston too quickly leads to compression of the rubber piston, followed by delivery of insulin when the piston returns to its original dimensions.

[0056] The EOC feature prevents the user from setting a dose larger than what is left in the cartridge. The EOC member 128 is rotationally locked to the reset tube, which allows the EOC member to rotate during dose setting, resetting, and dose delivery, while still being able to move axially back and forth along the threads of the piston rod. When the proximal end of the piston rod is reached, a stop is provided that prevents all connected parts, including the dial member, from further rotating in the dose setting direction, i.e., the set dose now corresponds to the remaining drug content in the cartridge.

[0057] The scale drum 170 is provided with a distal stop surface 174 adapted to engage a corresponding stop surface on the inner surface of the housing, which provides a maximum dose stop for the scale drum and prevents all connected parts, including the dial member, from being rotated further in the dose setting direction. In the embodiment shown, the maximum dose is set at 80 IU. Correspondingly, the scale drum is provided with a proximal stop surface adapted to engage a corresponding stop surface on the spring base member, which prevents all connected parts, including the dial member, from being rotated further in the dose ejection direction, thereby providing a "zero" stop for the entire ejection mechanism.

[0058] The EOC member functions to provide a security system to prevent accidental overdosing if any obstruction in the dial mechanism allows the scale drum to move beyond the zero position. More specifically, in the initial state with a full cartridge, the EOC member is positioned in its axially most distal position in contact with the drive element. After a given dose is expelled, the EOC member is again positioned to contact the drive element. Accordingly, if the mechanism attempts to deliver a dose beyond the zero position, the EOC member locks against the drive element. Due to the tolerances and flexibility of the various components of the mechanism, the EOC may move a short distance, resulting in the expulsion of a small "overdose" of medication (e.g., 3-5 IU of insulin).

[0059] The dispensing mechanism further includes an end-of-dose (EOD) click function that provides clear feedback at the end of the dispensed dose, informing the user that the entire amount of medication has been dispensed. More specifically, the EOD function is achieved by the interaction between the spring base and the scale drum. As the scale drum returns to zero, a small click arm 106 on the spring base is forced backward by the advancing scale drum. Just before "zero," the arm is released and strikes a countersunk surface on the scale drum.

[0060] The illustrated mechanism is further provided with a torque limiter to protect the mechanism from overloads applied by the user via the dial member. This function is provided by the interface between the dial member and the reset tube, which, as described above, are rotationally locked to one another. More specifically, the dial member is provided with a circumferential internal tooth structure 181 that engages with several corresponding external teeth 161, which are disposed on the flexible carrier portion of the reset tube. The reset tube teeth are designed to transmit a specified maximum torque (e.g., 150-300 Nmm) above which the flexible carrier portion and teeth bend inward, rotating the dial member without rotating the rest of the dial mechanism. Therefore, the pen's internal mechanism is not stressed by loads higher than those transmitted by the torque limiter via the teeth.

[0061] Having explained the principles of operation of the mechanical drug delivery device, embodiments of the present invention will now be described.

[0062] 4A and 4B show schematic diagrams of a first assembly of a pre-filled pen-shaped medication delivery device 200 and an add-on dose log device 300 adapted therefor. The add-on device is adapted to be mounted on the proximal end portion of the pen device housing and is provided with dose setting and dose release means 380 that cover corresponding means on the pen device in the mounted state shown in FIG. 4B. In the embodiment shown, the add-on device includes a coupling portion 385 adapted to be axially mounted and rotationally locked on the medication delivery housing. The add-on device comprises a rotatable dose setting member 380, which is directly or indirectly coupled to the pen dose setting member 280 such that rotational movement of the add-on dose setting member is transmitted to the pen dose setting member in either direction during dose setting. In order to reduce external influences during dose ejection and dose sizing, the outer add-on dose setting member 380 may be rotationally decoupled from the pen dose setting member 280 during dose ejection, as will be described in more detail with reference to the embodiment of FIG. 5. The add-on device further includes a dose release member 390 that can move distally, thereby actuating the pen release member 290. As will be described in more detail below with reference to Figure 5, the add-on dose setting member that is grasped and rotated by the user may be attached directly to the pen housing in rotational engagement therewith.

[0063] Alternatively, the illustrated configuration may be adapted to function primarily as an aid for persons with reduced dexterity for setting and releasing a dose of medication, and therefore any dose sensing and dose logging functions may be omitted. In such a configuration, it is less important that the external add-on dose setting member is rotationally decoupled from the pen dose setting member 280 during dose ejection. Accordingly, the external add-on dose setting member may be in permanent rotational engagement with the pen dose setting member 280.

[0064] Turning to FIG. 5, a first exemplary embodiment of an add-on dose logging device 400 adapted to be mounted on a pen-type medication delivery device 100 is described in more detail. The medication delivery device essentially corresponds to the medication delivery device described with reference to FIGS. 1-3 and therefore includes a housing 101, a rotatable dose setting member 180 allowing the user to set the dose of medication to be expelled, a release member 190 actuable between a proximal dose setting position and a distal dose release position, a scale drum 170, and a reset tube 160. To cooperate with the add-on logging device, the medication delivery device is modified to include a generally ring-shaped tracer magnet 160M attached to or integrally formed with the proximal end of the reset tube, the magnet serving as an indicator that rotates during dose expulsion, the amount of rotational movement being indicative of the size of the expelled dose. Furthermore, the housing is provided with a circumferential groove 101G immediately distal to the dose setting member, which serves as a coupling means for the add-on device.

[0065] The add-on device includes an outer assembly 410 as well as an inner assembly 480 that are removably attachable to the medication delivery device housing. The inner and outer assemblies are rotationally locked to each other during dose setting, but are rotationally uncoupled from each other during dose ejection. The embodiment shown is based on an experimental prototype, and as such, part of the structure is formed from multiple assembled parts.

[0066] The outer assembly 410 includes a generally cylindrical housing member 411 that defines a general axis for the add-on device and functions as an add-on dose setting member, a distally disposed coupling means 415 adapted to engage the coupling groove 101G of the pen housing, and a proximally disposed dose release member 490 coupled to the housing member 411 and axially movable between an initial proximal position and an actuated distal position. In the illustrated embodiment, the coupling means 415 is in the form of a number of spring-loaded coupling members adapted to be removably received in the housing groove 101G by a snap action when the add-on device is slid onto the proximal end of the medication delivery device 100, whereby the coupling means axially locks the add-on device to the pen device. The coupling means may be released, for example, by a pulling action or by actuation of a release mechanism. The housing includes an inner circumferential flange 412 and a number of axially oriented guide grooves 413 at the proximal portion. The dose release member 490 comprises a number of axially oriented, circumferentially arranged flanges 493 received within guide grooves 413, which provide proximal stops against which the dose release member is biased by a first return spring 418 supported between the housing flange 412 and the dose release member 490. The dose release member comprises an inner cylindrical skirt portion 492 having a distal inner flange portion 494 which includes a distal circumferential lip 495 and a proximal array of axially oriented locking splines 496.

[0067] The inner assembly 480 includes an inner housing 481 and an axially movable sensor system in the form of a sensor module 460 disposed therein. The inner housing comprises a proximal wall portion 482 from which a hollow transmission tube 483 extends proximally, an inner circumferential flange portion 484 that serves as a support for the second biasing spring 468, and a distally extending circumferential skirt portion 487 provided with a number of axially oriented inner protrusions adapted to be received within the drive groove 182 (see FIG. 1A) of the pen-type dose setting member, thereby rotationally locking the two members together, the engagement allowing for some axial play during installation and operation of the add-on device. Alternatively, the skirt portion 487 may be provided with a radially inwardly biased drive structure of the type described below. The hollow tube 483 includes at its proximal end a disk-shaped portion having a distally facing stop surface adapted to engage with a circumferential lip 495 and a circumferential array of axially oriented splines 486 adapted to engage with locking splines 496 on the dose release member 490, thereby rotationally locking the inner assembly to the dose release member and therefore the outer assembly.

[0068] The sensor module 460 includes a sensor portion and a proximally extending actuation rod portion 462. The sensor portion includes a generally cylindrical sensor housing 461 within which electronic circuitry 465 is disposed (shown schematically in FIG. 5 ). The sensor housing includes a distal actuation surface adapted to engage with the pen-style actuation member 190. In the initial dose setting mode (i.e., the dose release member 490 is in an initial proximal position), the sensor housing is biased proximally by the second biasing spring 468 into engagement with the inner housing proximal wall portion 482, and the actuation rod 462 extends from the transmission tube 483 into the interior of the dose release member 490, forming an axial gap between the proximal end 463 of the actuation rod and the inner actuation surface of the dose release member.

[0069] The electronic circuit 465 includes electronic components including processor means, one or more sensors, one or more switches, wireless transmitter / receiver means, and an energy source. The sensors comprise one or more magnetometers adapted to measure the magnetic field generated by the pen tracer magnet 160M, which enables rotational movement of the pen reset tube and thus determines the released dose size (see, e.g., WO 2014 / 161952). Additional sensor means may be provided to enable device type recognition, such as a color sensor adapted to determine the color of the light emitter and pen release member, which serves as an identifier for the medication type contained in the pre-filled pen device. The processor means may be in the form of a general microprocessor or ASIC, non-volatile program memory such as ROM providing storage for embedded program code, writeable memory such as flash memory and / or RAM for data, and a controller for the transmitter / receiver.

[0070] In the context of use with the add-on device 400 installed on the pen-based medication delivery device 100 shown in Figure 5, the user initiates setting the desired dose by rotating the housing member 411 (i.e., the add-on dose setting member) and therewith the dose release member 490. During dose setting, the dose release member is biased towards its initial proximal position, thereby rotationally locking to the inner assembly 480 via the locking splines 486, 496, which allows the rotational movement of the add-on dose setting member to be transmitted to the inner housing 461 and hence to the pen-based dose setting member 180.

[0071] Once the dose is set, the user actuates the dose release member 490 by moving the dose release member distally against the force of the first biasing spring 418. During the initial release movement, the locking splines 486, 496 are disengaged, which rotationally decouples the inner assembly 480 from the dose release member, and therefore from the add-on dose setting housing member 411. During further release movement, the dose release member 490 engages the actuation rod proximal end 463, such that during further release movement, the sensor module 460 moves distally toward the pen dose release member 190 and then contacts the pen release member. The engagement surfaces of the actuation rod 462 and the add-on dose release member 490 are optimized for minimal transmission of rotational movement. Finally, further distal movement of the add-on release member 490 results in actuation of the pen release member 190, thereby expelling the set dose, and thereby the sensor module 460 functions as an actuator.

[0072] To determine the dispensed dose size, the amount of rotation of the tracer magnet 160M, and therefore the reset tube 160, is determined. More specifically, the initial movement of the sensor module activates a sensor switch (not shown), which in turn activates the sensor electronics 465 and begins sampling data from the magnetometer, thereby enabling the start of rotation position of the tracer magnet 160M before the release mechanism is released. During this time, the color of the pen release member, and therefore the type of medication contained in the cartridge, can also be determined. Because the reset tube can rotate more than 360 degrees during the release of a dose of medication, the rotational movement during release is detected and the number of complete rotations, if any, is determined. When rotation of the reset tube is detected to have stopped—for example, when the set dose is completely dispensed or when external dosing is paused by the user—the end-of-rotation position is determined, allowing the dispensed dose size to be determined. Alternatively, the end-of-rotation position may be determined when the sensor switch detects that the sensor module 460 has returned to its initial position.

[0073] As shown, due to the rotational decoupling of the inner assembly 460 from the outer assembly 480 during drug delivery, movement of the outer components of the add-on device is highly prevented from adversely affecting the rotational movement of the reset tube 160 and the accurate determination of its rotational position.

[0074] The determined dose size (or data from which the dose size can later be calculated) is stored in a log memory along with a timestamp and a drug type identifier (if detected). The contents of the log memory may then be transmitted by NFC, Bluetooth, or other wireless means to an external device (e.g., a smartphone) paired with the add-on logging device. An example of a suitable pairing process is described in European Patent Application No. 17178059.6, which is incorporated herein by reference.

[0075] Referring to FIG. 6, a second exemplary embodiment of an add-on dose logging device 700 adapted to be mounted on a pen-type medication delivery device 600 will be described in more detail. The medication delivery device essentially corresponds to the medication delivery device described with reference to FIGS. 1-3 and therefore comprises a housing 601, a rotatable dose setting member 680 allowing the user to set the dose of medication to be expelled, a release member 690 actuable between a proximal dose setting position and a distal dose release position, a scale drum 670, and a reset tube 660. To cooperate with the add-on logging device 700, the medication delivery device is modified to include a generally ring-shaped magnet 660M attached to or integrally formed with the proximal end of the reset tube, the magnet serving as an indicator that rotates during dose expulsion, the amount of rotational movement being indicative of the size of the expelled dose. Furthermore, the proximal housing part 602 is provided with a number of protrusions 601P immediately distal to the dose setting member, which serve as coupling means for the add-on device. In the embodiment shown, three interlocking projections are equidistantly positioned on the housing.

[0076] The add-on device 700 includes an outer assembly 710 removably attachable to the medication delivery device housing, and an inner assembly (see below). The outer assembly 710 includes a generally cylindrical distal coupling portion 719 (as in the embodiment of FIG. 4A ) defining a general axis of the add-on device, the coupling portion having a generally cylindrical bore 7xx adapted to receive a corresponding generally cylindrical coupling portion of the medication delivery pen, and adapted to be axially and rotationally lockably attached to the medication delivery housing by means of a number of bayonet coupling structures 715 adapted to engage and removably snap-fit ​​into engagement with corresponding coupling protrusions 601P on the pen housing. The add-on device further includes a proximal dose setting member 711 rotatably mounted on the coupling portion, which, as in the embodiment of FIG. 5 , is coupled to the pen dose setting member 680 such that rotational movement of the add-on dose setting member 711 is transmitted to the pen dose setting member in either direction. The add-on device further includes a dose release member 790 that rotates with the dose setting member during dose setting. A first biasing spring 718 supported on an inner circumferential flange 712 on the dose setting member provides a proximally directed biasing force on the dose release member. As in the embodiment of Figure 5, the inner and outer assemblies are rotationally locked to each other during dose setting, but are rotationally decoupled from each other during dose ejection.

[0077] The inner assembly 780 generally corresponds to the inner assembly 480 of the embodiment of FIG. 5 and therefore generally includes the same structure providing the same functionality. Accordingly, the inner assembly (see FIG. 7A) includes an inner housing 781 and an axially movable sensor module 760 disposed therein. The inner housing comprises a proximal wall portion 782 from which a hollow transmission tube structure 783 extends proximally, a distal inner circumferential flange portion 784 that serves as a support for the second biasing spring 768, and a distally extending peripheral skirt portion 787 adapted to engage the drive groove 682 (see FIG. 6) of the pen-type dose setting member, whereby the two members are rotationally locked to one another, with the engagement allowing for some axial play during installation and operation of the add-on device. In the embodiment shown, the structure that engages the drive groove 682 of the dose setting member is in the form of flexible fingers 751, which can facilitate installation, as described in more detail below. The fingers may be mounted on a skirt portion 787, for example formed as part of a metal plate member, as shown, or may be formed integrally with the skirt portion. The hollow tube 783 includes at its proximal end not only a number of flange portions 788 having distally facing stop surfaces adapted to engage with a circumferential inner flange 795 of the dose release member 790, but also a number of axially oriented splines adapted to engage locking splines 796 on the dose release member 790, thereby rotationally locking the inner assembly to the dose release member, and hence the outer assembly.

[0078] The sensor module 760 includes a sensor portion and a proximally extending actuation rod portion 762. The sensor portion comprises a generally cylindrical sensor housing 761 within which electronic circuitry 765 (see below) is disposed. The sensor housing includes a distal spacer cap 764 that covers the magnetic sensor and is adapted to engage with the pen-style actuation member 690. In the initial dose setting mode (i.e., with the dose release member 790 in an initial proximal position), the sensor housing is biased proximally by the second biasing spring 768 into engagement with the inner housing proximal wall portion 782, and the actuation rod 762 extends from the transfer tube 783 into the interior of the dose release member 790, forming an axial gap between the proximal end 763 of the actuation rod and the inner actuation surface of the dose release member.

[0079] The electronic circuit 765 includes electronic components including a processor means, a sensor, an activation switch (e.g., a dome switch activated by axial force applied on the actuation rod portion 762), a wireless transmitter / receiver means, and an energy source. More specifically, in the embodiment shown, the electronic circuit 765 comprises a layered structure including, from its distal end, a first PCB 766A having a number of sensor components (e.g., a magnetometer 766M) disposed thereon, a pair of battery connector disks 766B for a pair of coin cells, a second PCB 766C having most of the electronic components mounted thereon (e.g., a processor, transmitter / receiver, and memory), and a top disk 766D having a slot that allows the actuation rod portion 762 to contact and activate the activation switch 766S mounted on the PCB, the five components being interconnected by a flexible ribbon connector.

[0080] The sensor comprises a number of magnetometers adapted to measure the magnetic field generated by the pen magnet 660M, which allows rotational movement of the pen reset tube and thus determines the released dose size (see, e.g., WO2014 / 0161952). Additional sensor means may be provided to allow device type recognition, such as a color sensor adapted to determine the color of the light emitter and pen release member, which serves as an identifier for the medication type contained in the pre-filled pen device. The color sensor and light emitter may operate with visible light (to the human eye) or light completely or partially outside the visible spectrum. The processor means may be in the form of a general microprocessor or ASIC, a non-volatile program memory such as ROM providing storage for embedded program code, a writable memory such as flash memory and / or RAM for data, and a controller for the transmitter / receiver.

[0081] In the context of use with the add-on device 700 installed on the pen-based medication delivery device 600, the user initiates setting the desired dose by rotating the dose setting member 711 (i.e., the add-on dose setting member) and therewith the dose release member 790. During dose setting, the dose release member is biased towards its initial proximal position, thereby rotationally locking to the inner assembly 780 via the locking splines 786, 796, which allows the rotational movement of the add-on dose setting member to be transmitted to the inner housing 761 and hence to the pen-based dose setting member 680.

[0082] Once the dose is set, the user actuates the dose release member 790 by moving the dose release member distally against the force of the first biasing spring 718. During the initial release movement, the locking splines 786, 796 are disengaged, which rotationally decouples the inner assembly with electronics 780 from the dose release member 790 and therefore from the add-on dose setting member 711. During further release movement, the dose release member 790 engages with the actuation rod proximal end 763 (see FIG. 8A), which causes the sensor module 760 to move distally towards the pen-type release member 690 during further release movement and then contact the pen-type release member (see FIG. 8B). The engagement surfaces of the actuation rod 762 and the add-on dose release member 790 are optimized for minimal transmission of rotational movement. Finally, further distal movement of the add-on release member 790 results in actuation of the pen release member 690 (see FIG. 8C, where the reset tube outer teeth 661 are moved distally), thereby expelling the set dose (see FIG. 8D), thereby causing the sensor module 760 to function as an actuator.

[0083] To determine the dispensed dose size, the amount of rotation of the magnet 660M, and therefore the reset tube 660, is determined. More specifically, the initial movement of the sensor module activates the sensor switch, which in turn activates the sensor electronics 765 and begins sampling data from the magnetometer, thereby determining the starting rotation position of the magnetometer 660M before the release mechanism is released. During this time, the color of the pen release element, and therefore the type of medication contained in the cartridge, can also be determined. Because the reset tube 660 rotates more than 360 degrees during the release of a medication dose, the rotational movement during release is detected and the number of full rotations (if any) is determined. When rotation of the reset tube is detected to have stopped—for example, when the set dose is fully dispensed or when external dosing is paused by the user—the end-of-rotation position is determined, allowing the dispensed dose size to be determined. Alternatively, the end-of-rotation position may be determined when the sensor switch detects that the sensor module 760 has returned to its initial position.

[0084] As shown, due to the rotational decoupling of the inner assembly 760 from the outer assembly 780 during drug ejection, movement of the outer components of the add-on device is highly prevented from adversely affecting the rotational movement and accurate determination of the rotational position of the reset tube 660.

[0085] 9, a third exemplary embodiment of an add-on dose logging device 900 adapted for installation on a pen-type medication delivery device 800 will be described in more detail. A slightly modified medication delivery pen device 800 will be described with reference to FIGS. 10A and 10B.

[0086] The add-on dose logging device 900 essentially corresponds to the add-on dose logging device 600 described with reference to Figures 6 to 8 and therefore includes an outer assembly removably attachable to the medication delivery device housing, an inner assembly having a sensor module as well as a release member assembly. In contrast to the above-described embodiments, the exploded view of Figure 9 shows the individual components from which the assembly is formed.

[0087] The outer assembly is formed by a distal housing connecting portion 901, a proximal housing portion 919 mountable thereto, an add-on dose setting member 911 adapted to be freely rotatably mounted on the proximal housing portion, and a locking ring 916 adapted to be mounted on the dose setting member and enclose the release member assembly. The locking assembly comprises a release slider 908, a capture member 905, a biasing spring 906 as well as a pair of return coil springs 909 for the slider, the locking assembly components being adapted to be mounted within the housing connecting portion 901.

[0088] More specifically, the distal housing coupling portion 901 includes a cylindrical bore 902 adapted to snugly receive a corresponding cylindrical coupling portion of the medication delivery pen device (see below). The bore is provided with a distally facing, axially oriented groove adapted to receive the pen housing locking projection 805 when the add-on device is axially mounted on the pen device. The proximal portion of the distal housing coupling portion tapers outwardly to a larger diameter and includes a plurality of longitudinal ribs 907, each having a proximally facing end face that serves as a distal stop for the inner assembly. The coupling portion 901 includes a window opening 904 adapted to cover the pen device display window when mounted, thereby allowing the display window, and therefore the scale drum, to be viewed. Opposite the window opening is provided a second opening 903 adapted to receive a locking assembly component. The capture member 905 is pivotally mounted within the second opening and is biased inward by a biasing spring 906, which enables the capture member to snap into position distal to the pen-type housing locking protrusion 805 when the add-on device is axially mounted on the pen-type device. The locking means is disposed opposite the window opening 904, ensuring that the user can easily rotationally orient the add-on device during installation. The release slider 908 is slidably mounted within the second opening and is biased distally by a return spring 909. When the user moves the release slider proximally, this lifts the capture member 905 out of engagement with the housing locking protrusion 805, allowing the add-on device to be moved proximally and therefore removed from the pen-type device. The proximal housing portion 919 is fixedly attached to the connecting portion 901, for example by welding, adhesive, or snap means, and includes a circumferential ridge 917 that allows the dose setting member 911 to be freely rotatably mounted by a snap action.The dose setting member, in the assembled state, includes a number of axially extending inner flanges forming a number of guide tracks 913 for the release member assembly, as well as a circumferential inner flange 912 which functions as a proximal stop for the inner assembly and a distal stop for the release member return spring 918. A locking ring 916 is adapted to be axially fixedly mounted to the dose setting member, for example by welding, adhesive or snap means, as shown, and thereby seal a gap between the dose setting member 911 and the cap member 998.

[0089] The inner assembly includes a generally cylindrical inner housing member 981, a cylindrical locking member 950 adapted to be mounted on the inner housing member, and a proximal wall or lid member 982 adapted to attach to the inner housing member and enclose a sensor module mounted thereon. The wall member includes a proximally extending tube portion 983 adapted to receive a proximal flange member 988.

[0090] More specifically, inner housing member 981 includes a larger diameter distal skirt portion 987 having multiple openings 989 and a smaller diameter proximal portion having multiple axially extending wall sections 985 that form multiple guide tracks for the sensor module. The transition between the two portions forms an outer circumferential distal support 984 for sensor spring 968 (see below). In the illustrated embodiment, cylindrical locking member 950 is formed from a single piece of sheet metal into which are formed a first plurality of axially extending flexible dial locking arms 951, each having a radially inwardly extending proximal free end portion, and a second plurality of axially extending flexible locating arms 955, each having a radially inwardly extending proximal free end portion. The locating arms function to snap into engagement with corresponding locating openings 989 when the locking member is installed on inner housing member 981, which axially and rotationally locks the two members. The distal end of the dial lock arm 951 is inwardly radiused and adapted to engage with the drive groove 882 of the pen-type dose setting member (see below). The proximal wall member 982 is adapted to be fixedly attached to the inner housing flange, for example, by welding, adhesive, or snap means, and serves as a proximal stop for the sensor module in the assembled state. The proximally extending tube portion 983 includes at its proximal end a pair of opposing radial extensions, each including a plurality of axially oriented locking splines 986 adapted to engage corresponding splines on the release member in the assembled state. The proximal flange member 988 is adapted to be fixedly attached to the tube portion 983, for example, by welding, adhesive, or snap means, as shown. The flange member includes a central bore having a smaller diameter than the larger-diameter distal end of the actuation rod 962 (see below), which provides a proximal stop for the actuation rod.

[0091] The sensor module 960 includes a generally cylindrical sensor housing 961 having mounted thereon an electronic circuit 965 having a distally facing sensor component, a spacer cap 964 mounted on the sensor module housing distal end and adapted to cover and enclose the sensor component, and an actuation rod 962 adapted to be disposed within the wall member tube portion 983. A sensor module return spring 968 is disposed between the inner housing member 981 and the sensor housing 961 and adapted to provide a proximal biasing force to the sensor module.

[0092] More specifically, the spacer cap 964 is adapted to be fixedly attached to the sensor housing by, for example, welding, adhesive, or snap means, and in the assembled state protects the sensor components and serves as a distal-facing contact surface adapted to engage with the pen device release member 890 (see FIG. 13A ). The sensor housing includes multiple radially protruding distal and proximal guide flanges 967 adapted to be freely axially, but not rotatably, received within the inner housing member guide track. The distal guide flanges also provide proximal stop surfaces for the sensor spring 968. A distal stop for the sensor module is provided by the inner housing corresponding to the distal end of the guide track and / or the compressed sensor spring. The actuation rod 962 includes a larger-diameter distal portion that allows the rod to be freely received within the tube portion 983 and a smaller-diameter proximal portion adapted to protrude through a hole in the flange member 988. The actuation rod includes a rounded proximal end 963, and the engagement surfaces of the actuation rod and cap member 998 are optimized for minimal transmission of rotational movement. The sensor module includes a proximally-facing, centrally-disposed actuation switch 966 (e.g., a dome switch) adapted to be actuated by the actuation rod.

[0093] The release member assembly includes a body member 990 and a cap member 998 mountable thereon. A release member return spring 918 is disposed between the dose setting member flange 912 and the release body member 990 and adapted to provide a proximally directed biasing force on the release body member.

[0094] More specifically, release body member 990 includes a distal ring portion 994 having an inner circumferential array of axially oriented splines 996 that, in the assembled state, are adapted to engage locking splines 986 on tube portion 983, as well as a number of radially protruding guide flanges 993 that are adapted to be non-rotatably but axially freely received within dose setting member guide track 913. A cap member 998 is adapted to be axially fixedly attached to the body member, for example, by welding, adhesive, or snap means 995, as shown. In the assembled state, flange member 988 functions as a proximal stop for release body member 990, and release member return spring 918 acts on the ring portion distal surface.

[0095] Turning to Figures 10A and 10B, the proximal portion of a slightly modified pen medication delivery device 800 is shown in combination with parts of the inner assembly of the add-on device that provide rotational engagement between the add-on device and the pen dose setting member.

[0096] More specifically, the pen housing 801 generally corresponds to the embodiment of FIG. 6, but instead of a slightly tapered housing, the proximal coupling portion 802 of the housing, including the window 809, has a "true" cylindrical form adapted to be received within a cylindrical bore of the add-on device. Alternatively, both structures may have a slight taper. Furthermore, the coupling means is in the form of a single locking protrusion 805 adapted to cooperate with a capture member 905 for easy axial installation. Also shown is a dose setting member 880 having a generally cylindrical outer surface 881 (i.e., the dose setting member may be slightly tapered), and in the embodiment shown, the outer surface is textured by including a plurality of axially oriented microgrooves to improve finger grip during dose setting, as well as a number of axially oriented drive grooves 882 corresponding to the embodiment of FIG. 6.

[0097] As described above with reference to Figures 9A and 9B, the inner assembly includes not only a housing member 981 having a distal skirt portion 987 with a number of openings 989, but also a cylindrical locking member 950 mounted thereon, the locking member including a number of flexible dial locking arms 951 and a number of flexible mounting arms (the latter not shown in Figures 10A and 10B).

[0098] In FIG. 10A , the inner housing 981 is shown in its axially installed position (as determined by non-illustrated parts of the add-on device). While the outer add-on housing 901 is rotationally installed in a predetermined position, this is not the case for an inner housing assembly that is free to rotate relative to the outer housing when not installed, which is assumed to be mounted in a “random” rotational position such that the inner housing, and therefore the locking arm 951, is not rotationally aligned with the drive groove 882 of the dose setting member. Furthermore, the dose setting member 880 has an initial “parked” rotational “zero” position corresponding to no dose being set, but may also be set to a random position. Furthermore, even when parked in the zero position, looseness in the dose setting mechanism may result in slight variations in the rotational position of the drive groove of the dose setting member.

[0099] Therefore, when the add-on device is installed on the pen device, the flexible dial locking arms 951 may not be rotationally aligned with the drive groove 882 of the dose setting member. However, due to the flexibility of the dial locking arms, they are moved outward by the dose setting member and slide axially on the outer periphery of the dose setting member parallel to the drive groove, as shown in FIG. 10A . Because the resistance provided by the flexible locking arms is small, the user will in most cases not be aware of what has happened during installation of the add-on device and will not be aware of the fact that the add-on device has not yet rotationally engaged with the dose setting member of the pen device. In the embodiment shown, the free ends of the locking arms 951 are directed proximally, but alternatively, they may be oriented distally, and the free ends of the locking arms and the proximal edge of the dose setting member 880 of the pen device may be configured to move the locking arms outward during installation of the add-on device.

[0100] Thereafter, when the user wishes to set a dose, the user begins to rotate the add-on device dose setting member 911, which causes the inner housing to rotate with the locking arms 951, which then align with the drive groove 882 of the dose setting member, and thus bend inward to rotationally engage with the drive groove, as shown in FIG. 10B. To ensure that the locking arms easily engage with the drive groove, they are formed slightly narrower than the drive groove. Further movement of the add-on device dose setting member 911 then causes the dose setting member of the pen device to rotate accordingly, which allows the user to set and adjust the dose as normal. Indeed, in many cases, the locking arms are moved directly into the drive groove.

[0101] The number and mechanical properties of the locking arms 951 should be dimensioned to allow safe and robust operation of the add-on device. To ensure this, the combined assembly, i.e., pen device and add-on device, may include an over-torque mechanism in case the user attempts to dial below zero or above the maximum settable dose. For add-on devices, the over-torque mechanism may be incorporated into the spline engagement between the inner housing assembly and the add-on dose setting member, but in most cases, such a mechanism for add-on devices can be omitted because pen devices are typically provided with an over-torque protection mechanism (e.g., as known from the FlexTouch® medication delivery pen). In fact, the locking arms 951 and the drive groove 882 of the dose setting member should be designed and dimensioned to withstand torques that exceed the limit for the pen device over-torque mechanism.

[0102] Figures 11A and 11B show cross-sectional views of the locking arm 951 when it engages with the outer circumference of the dose setting member 880 of the pen device and when it engages with the drive groove 882 of the dose setting member of the pen device, respectively.

[0103] 12A and 12B, the components of FIG. 9A are shown in an assembled state corresponding to an initial, un-installed and un-activated state.

[0104] 12A shows the sensor module 960 disposed inside the inner assembly and biased toward its proximal-most position by a sensor spring 968 acting between an inner housing spring support 984 and a sensor housing distal guide flange 967. A dial lock arm 951 can be seen protruding into the inner housing skirt portion 987. A release body member 990 is biased toward its proximal-most position by a release member return spring 918 acting between the dose setting member inner flange 912 and a release body member ring portion 994. An actuation rod 962 is disposed inside the inner housing tube portion 983 and is held in axial position by a flange member 988, with an axial gap formed between the actuation rod proximal end 963 and the distal surface of a cap member 998. The inner housing and release member assembly are rotationally locked to one another via a splined engagement between tube portion 983 and release body member 990 (not visible in FIG. 12A).

[0105] 13A-13F, different operational states of a third exemplary embodiment of an add-on dose logging device 900 in combination with a pen-type medication delivery device 800 are described. The pen-type device shown is in the form of a FlexTouch® pre-filled medication delivery device manufactured by Novo Nordisk A / S.

[0106] 13A shows an add-on dose logging device 900 before installation on a pen-type medication delivery device 800. As described above, the medication delivery device includes a proximal coupling portion 802 having a "true" cylindrical configuration adapted to be received in a cylindrical bore of the add-on device, a window 809, a locking protrusion 805 adapted to cooperate with a capture member 905 of the add-on device, a dose setting member 880 having a generally cylindrical outer surface 881 with a number of axially oriented drive grooves 882, and a proximally disposed release member 890. The add-on device 900 includes a cylindrical bore 902 adapted to receive the cylindrical coupling portion 802 of the pen-type device, a capture member 905 adapted to engage with the locking protrusion 805, a window opening 904 arranged to be installed in registration with the window 809 of the pen-type device, a dose setting member 911, and a dose release member 998. A dial locking arm 951 can be seen protruding into the bore 902. Corresponding to FIG. 12A, the add-on device is in its initial, un-installed and un-activated state.

[0107] 13B, the add-on device 900 is installed on the pen-type device 800, the capture member 905 is located distal to the locking protrusion 805, and the two windows 904, 809 are aligned. Corresponding to the situation shown in FIG. 10A, the dial locking arm 951 is not yet engaged with the drive groove 882.

[0108] In Figure 13C, the add-on dose setting member 911, and thereby the inner assembly, has been rotated so that the dial lock arm 951 is engaged with the drive groove 882 and the dose is set.

[0109] In FIG. 13D, the add-on dose release member 998 is partially actuated, The add-on dose release member 998 engages the rounded proximal end 963 of the actuation rod, and in this state the inner circumferential array of axially oriented splines 996 on the release body member 990 are disengaged with the locking splines 986 of the tube portion 983, thereby rotationally separating the dose setting member 911 from the inner assembly and therefore the sensor module 960. Further distal movement of the add-on dose release member 998 begins to move the actuation rod 962 distally, which initially causes the actuation rod to actuate a proximally-facing, centrally disposed activation switch 966 (see FIG. 9 ), which changes the sensor module to its operative state.

[0110] In FIG. 13E, the add-on dose release member 998 is further actuated, moving the sensor module spacer cap 964 into engagement with the pen device release member 890 .

[0111] In Figure 13F, the add-on dose release member 998 has been fully actuated, and the sensor module, and thereby the release member 890 of the pen device, has moved to its distal-most operating position, which releases the ejection mechanism, thereby expelling the set dose of medication through a hollow needle located on a pre-filled cartridge. A determination of the size of the ejected dose may be made as described above with reference to Figures 8A-8D. Once the set dose is released, the user may release pressure on the add-on dose release member 998, and the return springs 968, 918 will return the component to its initial axial position.

[0112] Having described the mechanical concept and operating principles of the add-on dose log devices of Figures 5, 7A, and 12A, the sensor and tracer system itself will now be described in more detail. Essentially, the sensor and tracer system includes a moving magnetic tracer component and a sensor system that includes one or more magnetometers (e.g., a 3D compass sensor).

[0113] In an exemplary embodiment, the magnetic tracer component is in the form of a multipole magnet (i.e., a quadrupole magnet) having four poles. In FIG. 14, four dipole standard magnets 661 are arranged equidistantly within the ring-shaped tracer component 660M, and the four individual dipole magnets provide a combined quadrupole magnet with quadrupole offsets of 90 degrees. In effect, each dipole magnet is formed by a large number of individual magnetic particles oriented in the same direction. The individual magnets may be arranged in the same plane or axially offset from each other.

[0114] Alternatively, the multipole magnet 660M can be created by magnetizing a magnetizable material either by the use of individual strong magnets, as shown in FIG. 15A, or through the use of an electromagnetic field, as shown in FIG. 15B.

[0115] A given sensor system may use, for example, four, five, six, or eight magnetometers 766M arranged relative to the tracer component 660M as illustrated in FIG. 16. The sensors may be arranged in the same plane, as shown in FIG. 7B, for example, or may be axially offset from one another. More sensors and smaller spacing between sensors allow for more data to be collected, therefore with a better signal-to-noise ratio. However, more sensors require more data processing and consume more power.

[0116] In some cases, it is not just interference from external fields that needs to be addressed: the torque-providing spring for driving the dose-ejection motor in the disposable device described above may become magnetized when subjected to an external magnetic field, thus resulting in an internal interfering magnetic field.

[0117] Because external disturbances affect all sensors more or less equally and in the same direction, where external disturbances can be largely canceled out by signal processing algorithms, magnetized torque springs are more likely to affect sensors in the same way as tracer magnets and thus offset measurements and introduce errors.

[0118] However, as can be seen from Figures 17A and 17B, using a quadrupole tracer magnet instead of a dipole tracer magnet significantly reduces the error in determining the position of the tracer magnet.

[0119] More specifically, Figures 17A and 17B show simulated effects of a magnetized torque spring at four different levels of magnetization (TS1-TS4) on both dose configuration (DS) and external dosing (D). Figure 17A illustrates the calculated angle measurement error (i.e., the difference between the calculated angle and the true angle) for a dipole tracer magnet combined with a four-sensor setup, and Figure 17B illustrates the calculated angle measurement error for a quadrupole tracer magnet combined with an eight-sensor setup. Because the sensors are closer to the tracer magnet during external dosing (see, e.g., Figures 8A and 8C), the angle error is slightly smaller during external dosing. That is, in the above-described embodiment, sensor measurements are only taken during external dosing. Eight sensors were used for the quadrupole tracer magnet because the smaller circumferential spacing between the individual poles in the quadrupole tracer magnet provides a higher input rate to the sensor system, which can be more accurately captured by eight sensors instead of four; however, comparable results would be expected for a quadrupole tracer magnet combined with a four-sensor setup. As shown, the use of the quadrupole tracer magnet reduced the angular error by approximately eight times, from about 4-8 degrees to about 0.5-1 degree.

[0120] In the illustrated FlexTouch® drug delivery device, the reset tube 660, and therefore the tracer magnet 660M, rotates 15 degrees for each unit of insulin expelled. Therefore, an angular error, which can occur in the range of 4 to 8 degrees, can result in an erroneous determination of the expelled dose.

[0121] Therefore, quadrupole tracer magnets reduce the system's susceptibility to disturbances not only from external fields but also from internal fields. This is an important aspect of the use of multipole tracer magnets, because traditional magnetic shielding of external sources by using iron-containing metal sheets may be used to reduce the influence of external fields, but may not be able to fit between the tracer magnet and the internal disturbance magnetic field. Furthermore, incorporating magnetic shielding takes up space and incurs additional costs.

[0122] Alternatively, this may be alleviated by using a spring of a non-magnetizable material, however current spring-driven pens on the market today have magnetizable torque springs and replacement may not be feasible due to other requirements of the spring.

[0123] Having described the structural setup for a sensor assembly incorporating a rotating quadrupole tracer magnet, an exemplary method for determining actual movement for such an assembly is described below.

[0124] The signal from the quadrupole magnet is periodic, with two signals per period over one complete rotation of the magnet. This can be seen from Figure 18, where the tangential, radial, and axial magnetic field levels are depicted.

[0125] Mapping the frequency content of the signal shows that most of the signal from the magnet fits into two signals in frequency (see Figure 19).

[0126] To determine the dose size to use in the quadrupole field, the static start and end angles of the quadrupole magnet must be determined. Because the magnet is static before and after the dose is delivered, the magnetic field is sampled over space instead of over time. In an exemplary embodiment, the measurement system is configured with N=7 sensors using a circular layout and equal spacing; see Figure 20, which shows the placement of sensors 766M relative to quadrupole magnet 660M.

[0127] To determine the magnet orientation, a discrete Fourier transform (DFT) was calculated on the magnetic field measured by the sensor. TIFF2024161371000002.tif16170

[0128] where TIFF2024161371000003.tif6170 is the magnetic field of the jth channel of the kth sensor, where j=1 is the tangential magnetic field, j=2 is the radial direction, and j=3 is the axial direction; TIFF2024161371000004.tif7170 is a virtual unit, and TIFF2024161371000005.tif7170 is the nth frequency component of the signal in the jth channel.

[0129] As mentioned above, the signal from the quadrupole magnet is n=2 signals per period, so By looking at the phase of TIFF2024161371000006.tif7170, the orientation of the magnet relative to the sensor board can be determined. TIFF2024161371000007.tif10170

[0130] Since sine and cosine samples at different frequencies are orthogonal, any disturbances to a signal with period n=0, 1, or 3, for example, are removed by the Fourier transform.

[0131] This relates to both external and internal disturbances. An internal component within an automatic dose pen injector is a metal torsion spring to drive the dose mechanism. If this is magnetized, the spring field will appear primarily as a period 1 signal at the sensor location. External disturbances, such as a dipole magnet in the vicinity of the sensor, will also tend to have a period 0 or 1 signal. Using DFT, it is possible to remove disturbances from other frequencies and determine the magnet orientation from only the frequency 2 signal.

[0132] Therefore, the combination of quadrupole magnets with DFT is superior compared to dipole magnets, whose period 1 signal is similar to the frequency of common disturbances.

[0133] The use of DFT-based algorithms allows greater freedom to choose any number of sensors compared to lookup-based algorithms. The number of sensors chosen should preferably be at least five due to the Nyquist sampling theorem. Besides that, the number of sensors can be freely and aggressively used to remove certain frequencies of the signal in order to prevent aliasing effects.

[0134] With reference to the above exemplary embodiments, it has been explained that the initial movement of the sensor module activates the sensor switch, which in turn activates the sensor electronics and initiates sampling of data from the magnetometer, which allows the starting position of the magnet's rotational direction to be determined before the ejection mechanism is released. When it is detected that the rotation of the reset tube has stopped, for example, when the set dose has been completely ejected or when external dosing is paused by the user, the rotation end position is determined, which allows the size of the ejected dose to be determined. Alternatively, the rotation end position may be determined when the sensor switch detects that the sensor module has returned to its initial position.

[0135] The sampling frequency must be selected to reliably detect rotational movement and be as power-efficient as possible. However, analysis of the rotational speed during external dosing in a spring-driven device showed that the rotational speed of the reset tube is not constant. It was found that the rotational speed of the reset tube can be very high, particularly at the beginning of an ejection event. Two reasons for the high rotational speed have been identified. First, the cartridge rubber piston is in an uncompressed state before the external dosing event begins. When the energy in the drive spring is suddenly released, the rubber piston begins to compress before it begins to move distally within the cartridge. When sufficient pressure builds up in the cartridge, the piston begins to move, and the contents of the cartridge begin to flow out of the needle. The plunger compression occurs very quickly, but its speed decreases during compression.

[0136] Another reason is if there is an air gap between the piston rod and the cartridge piston, which can occur, for example, if the user leaves the needle on the drug delivery device after use or due to temperature cycling. Due to the lack of reaction force from the rubber piston, the ejection mechanism rotates very quickly after the piston rod hits the piston until the aforementioned piston compression begins.

[0137] When detecting component rotations to estimate the expelled dose volume, it is important to accurately count all rotations, otherwise this may lead to an underestimated dose, which could cause the user to ingest another dose and suffer a severe overdose.

[0138] When using an active sensor to sample the position of a component, for example, by measuring changes in a magnetic field, a high rotational speed requires a high sampling frequency to capture every rotation. However, using a high sampling frequency can consume a lot of power and collect a large amount of data that must be stored. This can lead to high power usage and memory shortages. This is particularly problematic for memory devices that are powered by a non-replaceable energy source. In contrast, if the frequency is too low, one or more signal cycles may not be detected. The two situations are shown in Figures 23A and 23B, respectively.

[0139] To address this issue, a dynamic sampling scheme can be used based on (i) knowledge of system behavior and (ii) sensing the actual rotational speed of the measured components. The system can be expected to operate as follows: starting with a period of high-speed rotation of the ejection mechanism, followed by a period of normal / moderate rotational speed, and ending with no rotation when the set dose is fully ejected or ejection is stopped by the user. Thus, an adaptive sampling scheme can be implemented that adapts modes as the rotational speed changes and starts with a high sampling frequency.

[0140] An exemplary usage scenario corresponding to the above-described embodiment is shown in FIG. 24. More specifically, after setting the dose of medication to be expelled, the user presses the add-on release button, and continuous axial movement of the sensor module triggers the sensor switch, initiating continuous sampling and evaluation of the rotational speed, with the sampling frequency initially set to "high." The sensor module then engages the pen release button, releasing the pen ejection mechanism. Due to plunger compression and / or an air gap between the piston and piston rod, the ejection mechanism may initially rotate at a high speed for a shorter or longer period. As the ejection mechanism subsequently decelerates, the rotational speed may be detected to be lower than a first threshold (threshold 1), thereby adjusting the sample frequency to "low." Finally, when rotation is detected to have stopped, i.e., the rotational speed is lower than a second threshold (threshold 2), sampling stops to conserve power. In other embodiments, more than two thresholds may be used.

[0141] In an exemplary embodiment, the sensor circuit operates in two modes: an initial "tracking mode" and a subsequent "dosing mode." Immediately after switch actuation, a "snapshot" is taken using all (here, seven) sensors, the measurements representing the start of rotation position are read back into memory, and then tracking mode is entered with a sampling period of 0.9 ms.

[0142] During "normal" operation, the following occurs: The user activates the device with the set dose and operates the release button at the "normal" operating speed. After the initial snapshot, the sensor circuit continues tracking until a 5-degree rotation is observed over 6 samples = 5.1 ms, indicating the beginning of the fast phase. The 5-degree angle measurement may be performed using DFT phase measurement. The sensor circuit continues tracking during the fast phase, where two schemes can be used for angle measurement: (i) DFT phase measurement, which is unreliable when the magnet rotates at high speeds but can reliably detect when the fast phase ends by observing very few rotations over seven consecutive samples; and (ii) a "coarse" angle measurement scheme suitable for counting half rotations during the fast phase. Once the fast phase ends, the sensor circuit exits the tracking state and enters dosing mode with a sampling frequency of 50 ms, assuming there is no faster rotation phase for a given dosing event. During dosing mode, the magnet sensors (here, seven) may operate continuously according to the sampling rate or all simultaneously. In fact, the latter sampling mode increases energy consumption (by a factor of 7), but depending on the algorithm used, higher accuracy may be expected, which may offset this during the normal administration mode with lower sampling frequency.

[0143] If the user activates the device with no (zero) set dose, there is no rotation at all, so there is no fast rotation to detect. The sensor circuit continues tracking in a tracking state waiting for fast rotation to begin until a timeout state (e.g., 10 seconds) is reached. After the timeout, the sensor circuit assumes an error has occurred, such as pressing a button while the device is in a purse, and the dose may be recorded as an "unknown dose size."

[0144] Under certain rare conditions when a very small dose is set, e.g., 1 IU, depending on the design of the ejection mechanism and the method of dose dialing (e.g., if the user initially dials a dose greater than 1 IU and then dials down to 1 IU), the rotation of the indicator may fail to trigger the fast phase. In such cases, the sensor circuitry remains in the tracking phase with fast sampling until the activation switch is deactivated or a timeout is reached. If the switch is deactivated before the timeout, indicating actual use, the sensor circuitry looks at the DFT phase measurement to determine whether this was a 1 IU dose or a zero dose (in which case no dose is recorded).

[0145] To address the issue of "(fairly) fast" release button actuation, one can implement tolerance criteria that must be passed to prevent the sensor circuit from reporting an "unknown dose size." For example, the rotation between the first snapshot (DFT) and the DFT angle based on the first sample from the tracking phase must be small. Otherwise, it is taken as an indication that the release button actuation speed was too fast and the pen may have started dosing and rotated more than 180 degrees between the first snapshot and the start of tracking.

[0146] Indeed, other adaptive sampling schemes may be utilized, for example the sampling frequency may vary continuously with rotation speed for a given range of rotation speeds.

[0147] In the above disclosure, the problem of both external disturbance fields and internal disturbance fields from the torque spring of the pen-based device was addressed by the use of a quadrupole tracer magnet in combination with a sensor array containing multiple magnetometers. In what follows, this problem is addressed by a different approach, which may be used as an alternative to or in addition to the quadrupole design described above.

[0148] The use of magnetic shields to shield magnetic systems from outside interference is commonly known and used. Typically, shields are used as a barrier to contain magnetic fields and prevent them from affecting other systems, or as a barrier to contain and shield a system from being affected by external (unshielded) magnetic fields. Internal components of the system that may introduce interfering magnetic fields are typically located outside the system's shielded volume. Indeed, it may be possible to incorporate shielding into a medication delivery device that includes a drive spring made from a magnetizable material, but this may require a major redesign of the pen device, which may not be a cost-effective option.

[0149] Therefore, the technical problem to be solved is to provide a magnetic shield that prevents / reduces internal magnetic fields that interfere with the measurements of the magnetic sensors of a magnetometer-based acquisition device or assembly. Additionally, such a shield may also function to prevent / reduce interference from "normal" external magnetic fields.

[0150] The proposed solution is to introduce a mu-metal shield to not only shield the sensor system from external magnetic fields, but also to deflect any unintended internal magnetic fields caused by the torque spring toward the shield and reduce interference with the tracer magnet's magnetic field. Reducing the strength of the interfering magnetic field from the torque spring may allow the use of fewer sensors to obtain the required accuracy and redundancy, and therefore less signal processing requirements, which may allow both cost and power consumption to be reduced.

[0151] Mumetal is a nickel-iron soft magnetic alloy with very high magnetic permeability. It has several compositions containing approximately 80% nickel, 15% or a few percent molybdenum, and some compositions also contain small amounts of copper and chromium. Mumetal is highly ductile and workable, easily formed into the thin sheets needed for magnetic shielding. However, Mumetal articles require heat treatment after being processed into their final form. Magnetic shields made from Mumetal function by providing a path for magnetic field lines instead of sealing them around the shielded area. Mumetal provides what appears to be an "easier" path through air, which has a much lower relative permeability, thus diverting the magnetic field. However, Mumetal has a very low saturation level and is therefore not suitable for shielding against stronger magnetic fields.

[0152] 21 shows an assembly essentially corresponding to that shown in FIG. 8A , except that the drug delivery device torque spring 655 is shown, and the add-on dose logging device 1000 is provided with a cylindrical shield 1020 made of mu-metal that covers the axial length of the sensor and tracer magnet volume, as well as the proximal portion of the torque spring 655. The cylindrical mu-metal shield essentially absorbs magnetic field lines from the magnetized torque spring and guides them toward the circumferential shield, thereby limiting the extent of the torque spring's interfering magnetic field axially and therefore toward the sensor. At the same time, the cylindrical shield serves to reduce the effect of external magnetic fields (EMF) on the sensor electronics disposed within the cylindrical volume.

[0153] Although the cylindrical mu-metal shield 1020 essentially absorbs the magnetic field lines from the tracer magnet 660M as well, this impacts measurement performance to a lesser extent because (i) the torque spring 655 is disposed axially farther from the magnetic sensor 1066M than the tracer magnet, and (ii) the torque spring is disposed radially closer to the shield than the tracer magnet. In this way, the sensor system can measure the magnetic field from the tracer magnet because only a small portion of the magnetic field is absorbed by the shield, while the geometrical characteristics described above allow the magnetic field from the torque spring to be highly absorbed by the shield and therefore to a lesser extent impact the sensor.

[0154] 22 shows an embodiment of an add-on dose logging device 1100 in which a steel outer shield 1121 is applied to provide a path for the external magnetic field, capable of handling stronger magnetic fields without saturating. A mu-metal inner shield 1122 is arranged to provide a path for the relatively weak internal magnetic field created by the torque spring without being saturated by the strong external magnetic field.

[0155] In the above description of the exemplary embodiments, different structures and means for providing the described functionality for the different components have been described to the extent that the concept of the present invention is clear to those skilled in the art. The detailed construction and specification for the different components are considered to be the subject of normal design procedures carried out by those skilled in the art along the lines described herein.

Claims

1. 1. A drug delivery assembly comprising: a housing (101, 601, 801), a drug reservoir (113) or means for receiving a drug reservoir, - a drug discharge means, - a dose setting means allowing the user to set the dose of drug to be expelled; - a release means operable to enable said drug expelling means to expel a set dose; - an indicator (160, 160M, 660M) adapted to rotate relative to said housing during the ejection of a dose of drug, the amount of said rotation being indicative of the size of said ejected dose; a sensor system, a sensor assembly adapted to measure a characteristic of said indicator indicative of a rotational position and / or a rotational movement of said indicator, said sensor assembly comprising at least one sensor element (766M) adapted to operate at a first sampling frequency and at least one sensor element adapted to operate at a second, lower sampling frequency; - based on measurements from said at least one sensor element, (i) the rotational position(s) and / or amount of rotational movement of said indicator; and (ii) a processor configured to determine a rotational speed of the indicator; - the sensor system is operable between a non-operating state and an operating state; - when said sensor system is activated, at least one sensor element operates at said first sampling frequency, - a drug delivery assembly, wherein at least one sensor element operates at said second sampling frequency when a decrease in rotation speed is detected.

2. said sensor assembly comprises at least one sensor (766M) element adapted to operate at a non-timed sampling frequency; when said sensor system is activated, at least one sensor element adapted to operate at a non-punctual sampling frequency operates at said first sampling frequency, The drug delivery assembly of claim 1, wherein when a decrease in rotational speed is detected, the sampling frequency is reduced to the second sampling frequency of at least one sensor element adapted to operate at a non-timed sampling frequency and is operated at the first sampling frequency in an initial stage.

3. 3. A medication delivery assembly according to claim 1 or 2, wherein the sampling frequency for at least one sensor element is controlled in accordance with one or more predetermined threshold values ​​for the rotational speed.

4. - the sensor assembly comprises a plurality of sensor elements, a first number of sensors are operated for each sample at a first sampling frequency, A drug delivery assembly according to any of claims 1 to 3, wherein a second, larger number of sensors operates at a lower sampling frequency at each sample when a decrease in the rotation speed is detected.

5. A drug delivery assembly according to any preceding claim, wherein the indicator comprises a magnetic component (160M, 660M) and at least one sensor element (766M) is a magnetic sensor adapted to measure one or more components of a magnetic field.

6. 6. The medication delivery assembly of claim 5, wherein at least one magnetic sensor (766M) operates at a non-timed sampling frequency following detection of a decrease in rotational speed.

7. A medication delivery assembly according to any preceding claim, comprising a generally cylindrical medication reservoir (113) having an axially movable piston formed from a resilient material.

8. A drug delivery device (100, 600, 800) and an add-on device (400, 700, 900) adapted to be removably mounted on said drug delivery device, said drug delivery device comprising: said housing (101, 601, 801), - said drug reservoir (113) or said means for receiving a drug reservoir, said drug releasing means, The add-on device, A drug delivery assembly according to any of claims 1 to 7, comprising said sensor system.

9. The drug discharge means is - a rotatable dose setting member (180, 680, 880) that allows the user to set the dose of drug to be expelled; - a release member (190, 690, 890) actuatable between a proximal position and a distal position, said proximal position allowing the dosage to be set and said distal position allowing said drug release means to release the set dose; a drive spring (155, 655) arranged to be deformed during dose setting and released by said release member, thereby driving the expulsion of a quantity of medicament from said medicament reservoir; The add-on device, - an add-on housing (610, 710, 901) adapted to be removably attached to said medication delivery device housing; an add-on dose setting member (411, 680, 780, 911) adapted to engage, directly or indirectly, with said dose setting member; - (i) a proximal dose setting position, where the add-on dose setting member (680, 780) can be operated to rotate the dose setting member and set a dose when the add-on device is attached to the medication delivery device; The drug delivery assembly of claim 8, further comprising: (ii) an actuatable add-on release member (490, 690, 790, 998) axially movable relative to the add-on dose setting member between a distal dose release position, to which the release member moves when the add-on device is attached to the drug delivery device, to release the set dose.

10. An add-on device (400, 700, 900) adapted to be removably mounted on a drug delivery device (100, 600, 800), said drug delivery device comprising: a housing (101, 601, 801), a drug reservoir (113) or means for receiving a drug reservoir, - a drug release means, - a dose setting means allowing the user to set the dose of drug to be expelled; - a release means operable to enable said drug expelling means to expel a set dose; - an indicator (160, 160M, 660M) adapted to rotate relative to said housing during ejection of a dose of drug, the amount of said rotation being indicative of said size of the ejected dose, The add-on device, - an add-on housing (610, 710, 901) adapted to be removably attached to said medication delivery device housing; - a sensor assembly (965) adapted to measure a characteristic of the indicator indicative of a rotational position and / or a rotational movement of the indicator when the add-on device is attached to the medication delivery device, the sensor assembly comprising at least one sensor element (766M) adapted to operate at a first sampling frequency and at least one sensor element adapted to operate at a second, lower sampling frequency; - based on measurements from said at least one sensor element, (i) the rotational position(s) and / or amount of rotational movement of said indicator; and (ii) a processor configured to determine a rotational speed of the indicator; - the sensor system is operable between a non-operating state and an operating state; - when said sensor system is activated, at least one sensor element operates at said first sampling frequency, an add-on device (400, 700, 900), at least one sensor element operating at said second sampling frequency when a decrease in rotation speed is detected;

11. The add-on device of claim 10 , wherein at least one sensor element operates at the first sampling frequency initially and thereafter at the second, lower sampling frequency when a reduction in rotation speed is detected.

12. - the indicator comprises a magnetic component, The add-on device according to claim 11, wherein the at least one sensor element is a magnetic sensor adapted to measure one or more components of a magnetic field generated by the indicator magnetic component.

13. Add-on device according to any of claims 10 to 12, wherein the sampling frequency of at least one sensor element is controlled in accordance with one or more predetermined threshold values ​​for the rotational speed.

14. - the sensor assembly comprises a plurality of sensor elements, a first number of sensors are operated for each sample at a first sampling frequency, An add-on device according to any of claims 10 to 13, wherein a second, larger number of sensors operates at a lower sampling frequency for each sample when a decrease in rotation speed is detected.

15. an add-on dose setting member (411, 680, 780, 911) adapted to engage, directly or indirectly, with said dose setting member; - (i) a proximal dose setting position, where the add-on dose setting member can be operated to rotate the dose setting member and set a dose when the add-on device is attached to the medication delivery device; The add-on device according to any of claims 10 to 14, further comprising: (ii) an actuatable add-on release member (490, 690, 790, 998) axially movable relative to the add-on dose setting member between a distal dose release position, to which, when the add-on device is attached to the drug delivery device, the release member moves to said distal position to release the set dose.

16. 1. A method for capturing dose-related data from a medication delivery assembly, comprising: (i) a housing (101, 601, 801), a drug reservoir (113) or means for receiving a drug reservoir, - a drug release means, - a dose setting means allowing the user to set the dose of drug to be expelled; - a release means operable to enable said drug expelling means to expel a set dose; - an indicator (160, 160M, 660M) adapted to rotate relative to said housing during the ejection of a dose of drug, the amount of said rotation being indicative of the size of said ejected dose; a sensor system, a sensor assembly adapted to measure a characteristic of said indicator indicative of a rotational position and / or a rotational movement of said indicator, said sensor assembly comprising at least one sensor element (766M) adapted to operate at a first sampling frequency and at least one sensor element adapted to operate at a second, lower sampling frequency; - based on measurements from said at least one sensor element, (i) the rotational position(s) and / or amount of rotational movement of said indicator; and (ii) providing a medication delivery assembly comprising a sensor system comprising a processor configured to determine a rotational speed of the indicator; (ii) actuating the sensor system from a non-operational state to an operational state; (iii) operating at least one sensor element at the first sampling frequency; (iv) detecting a rotational speed of the indicator; (v) operating at least one sensor element at the second, lower sampling frequency when a decrease in rotational speed is detected.